524470 Stock Overview
Manufactures, markets, and sells pharmaceutical formulation products in India. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Syncom Formulations (India) Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹19.51 |
52 Week High | ₹27.94 |
52 Week Low | ₹10.60 |
Beta | 1.5 |
11 Month Change | 6.55% |
3 Month Change | -4.97% |
1 Year Change | 56.46% |
33 Year Change | 94.71% |
5 Year Change | 2,279.27% |
Change since IPO | 1,198.19% |
Recent News & Updates
Recent updates
Shareholder Returns
524470 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -6.2% | 0.5% | 0.5% |
1Y | 56.5% | 42.5% | 27.5% |
Return vs Industry: 524470 exceeded the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 524470 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
524470 volatility | |
---|---|
524470 Average Weekly Movement | 9.5% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.1% |
10% most volatile stocks in IN Market | 9.1% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524470's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524470's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | 998 | Vijay Bankda | www.syncomformulations.com |
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations.
Syncom Formulations (India) Limited Fundamentals Summary
524470 fundamental statistics | |
---|---|
Market cap | ₹18.34b |
Earnings (TTM) | ₹331.45m |
Revenue (TTM) | ₹3.28b |
55.3x
P/E Ratio5.6x
P/S RatioIs 524470 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524470 income statement (TTM) | |
---|---|
Revenue | ₹3.28b |
Cost of Revenue | ₹2.04b |
Gross Profit | ₹1.25b |
Other Expenses | ₹915.54m |
Earnings | ₹331.45m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.35 |
Gross Margin | 37.98% |
Net Profit Margin | 10.10% |
Debt/Equity Ratio | 4.5% |
How did 524470 perform over the long term?
See historical performance and comparison